Now Reading: Karnataka forms SIT to probe Rs 4.91 crore fake drugs racket
-
01
Karnataka forms SIT to probe Rs 4.91 crore fake drugs racket
Karnataka's government on Thursday set up a six-member Special Investigation Team (SIT) headed by Bengaluru joint commissioner of police C Vamshikrishna to probe a spurious drugs racket. The move follows a raid…
Karnataka's government on Thursday set up a six-member Special Investigation Team (SIT) headed by Bengaluru joint commissioner of police C Vamshikrishna to probe a spurious drugs racket. The move follows a raid by the Food and Drug Administration at a farmhouse in Bidadi, where drugs worth Rs 4.91 crore were seized. Four people have been arrested, and the seized stock will be produced before a Bengaluru South court.
Pharmacists and chemists have pushed back against suggestions that fake drugs entered through retail chains. M K Mayanna, president of the Bruhat Bengaluru Chemists and Druggists Association, said counterfeits may instead reach patients through hospital pharmacies, online sellers or intermediaries. C Jayaram of the Karnataka Pharma Retailers and Distributors Organisation demanded stricter regulation of drug margins, and the Karnataka Chemists and Distributors Association alleged that agents approach patients at government hospitals offering discounts of 30-40 percent without bills. The FDA said samples have been sent for lab testing and batch numbers have been blocked on its portal.
Indian Opinion Analysis
Both sources report the same raid and SIT formation but frame the threat differently. Times of India foregrounds the chemists' defensive argument, that fake drugs bypassed retail chains, and quotes association heads blaming intermediaries, online sellers and hospital agents. The Federal, reproducing PTI copy, leads with the FDA seizure value (Rs 4.91 crore) and official warnings about relabelling and expired drugs. Times gives the industry's self-exculpatory narrative space, while The Federal stays with the enforcement perspective. A careful reader notes that both sides agree fake critical-care drugs are circulating, the dispute is about which channel they use. The next actionable step is the SIT investigation, with arrests already made and lab tests pending.
Coverage: 2 sources, 2 neutral
Sources (2): timesofindia.indiatimes.com (neutral report), thefederal.com (neutral report)
This story was synthesised by AI from the 2 sources linked above.
Updated: this story now draws on 2 sources.
